Addiction Cure Therapeutic Sciences

Addiction Cure Therapeutic Sciences

Closed: Apr. 2023

About this raise

Addiction Cure Therapeutic Sciences, with a valuation of $6.05 million, is raising funds on NetCapital. It is a biotech firm aiming to treat and cure drug and alcohol addiction. The company is using a unique approach to cure addiction through erasing epigenetic bookmarks and rearranging them to support new behavior. The scientists at Addiction Cure Therapeutic Sciences are exploring the underlying epigenetic causes of addiction and targeting them for treatment. Jack Levine founded Addiction Cure Therapeutic Sciences in April 2020. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,070,000. The campaign proceeds will be used for lab compound testing, research and development, salaries, marketing, and trade shows.

Expand

Investment Overview

Not Funded: $0

Deal Terms

Total Commitments

Platform
Netcapital
Start Date
09/12/2022
Close Date
04/03/2023
Min. Goal
$10,000
Max Goal
$1,070,000
Min. Investment

$99

Security Type

Equity - Common

Series

Pre-Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$0.50

Pre-Money Valuation

$6,051,000

Company & Team

Company

Year Founded
2020
Industry
Healthcare & Pharmaceuticals
Tech Sector
Biotech
Distribution Model
B2B
Margin
Medium
Capital Intensity
High
Location
Coconut Creek, Florida
Business Type
Growth
Company Website
Visit Website

Team

Employees
4
Prior Founder Exits?
No
Founder Name
Jack Levine
Title
CEO

Funding data not publicly available

Financials

 Revenue
$0
 Monthly Burn
$226
 Runway
4.5 months

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-2,716

$-10,002

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$1,013

$0

Accounts Receivable

$0

$0

Total Assets

$1,013

$0

Short-Term Debt

$3,729

$150

Long-Term Debt

$0

$0

Total Liabilities

$3,729

$150

Create a free account today to gain access to Kingscrowd analytics and financials.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings Kingscrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Company Funding & Growth

Funding history

Total Prior Capital Raised
$0
VC Backed?
No
Close Date Platform Valuation Total Raised Security Type Status Reg Type
04/03/2023 Netcapital $6,051,000 $0 Equity - Common Not Funded RegCF
Create a free account today to gain access to Kingscrowd analytics.
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Addiction Cure Therapeutic Sciences on NetCapital 2022
Platform: Netcapital
Security Type: Equity - Common
Valuation: $6,051,000
Price per Share: $0.50

Follow company

Follow Addiction Cure Therapeutic Sciences on NetCapital 2022

Buy Addiction Cure Therapeutic Sciences's Deal Report

Warning: according to the close date for this deal, Addiction Cure Therapeutic Sciences may no longer be accepting investments.

Addiction Cure Therapeutic Sciences Deal Report

Get Kingscrowd's comprehensive report on Addiction Cure Therapeutic Sciences including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Addiction Cure Therapeutic Sciences is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Addiction Cure Therapeutic Sciences deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge